Trial Number
424-23
Conditions
Epilepsy, Seizure Disorder
Participant Age Range
18 years to 75 years
Participant Gender
Any
Enrolling Participants
Yes
Overview
“A Phase2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy”
A study to evaluate the effectiveness of Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in treating epilepsy.